47 episodes

Conversations about Life Science, Science, Entrepreneurship, Investment, Financial Literacy, Health, M&A, Technology, Pharma, and Philosophy. Do you want to stay updated? Join the LSG2G Community: https://lsg2g.substack.com/

Beginner's Mind Christian Soschner

    • Business

Conversations about Life Science, Science, Entrepreneurship, Investment, Financial Literacy, Health, M&A, Technology, Pharma, and Philosophy. Do you want to stay updated? Join the LSG2G Community: https://lsg2g.substack.com/

    #47: Sebastien Groyer - 7 Tales from 20 years of Deep Tech Life Science Venture Capital Investment

    #47: Sebastien Groyer - 7 Tales from 20 years of Deep Tech Life Science Venture Capital Investment

    Here is my conversation with Sebastien Groyer, Entrepreneur and Venture Capitalist

    Episode Links:
    Article to the Episode: https://lsg2g.substack.com/p/7-tales-from-20-years-of-deep-tech-42f
    Youtube: https://youtu.be/Ni3mEDM7-_c
    Sebastien Groyer: https://www.linkedin.com/in/sebastien-groyer-2438548/

    Podcast Links:
    Podcast Website: https://www.lifescienceget2gether.com/
    Community Partner: https://linktr.ee/lsg2g
    Christian Soschner: https://linktr.ee/soschner
    LSG2G Twitter: https://twitter.com/LGet2gether
    LSG2G Linkedin: https://www.linkedin.com/company/life-science-get2gether
    Podcast Episodes: https://pod.link/1493847125
    Episodes on YouTube:  https://www.youtube.com/playlist?list=PLlZfrwd6iXrQ3LIANISUpP22seS2CsCEV

    Timestamps:
    For those who want to listen to specific parts of the episode, here are the timestamps:

    00:00 Introduction
    02:35 How do VCs view planning in companies?
    05:59 How to Approach Investors when Plans Change
    11:00 What are Target Companies of VCs?
    15:15 Are VCs Going for First Movers or Rather Established Markets?
    19:30 How Detailed Should  Business Plans be when Pitching to VCs?
    23:50 Storytelling – From Rough to Detail
    27:15 The Reality of VC Life
    34:40 How Often Can You Follow Up with VCs before Ending Up on a Blacklist
    38:54 What is the Right Time to Approach VCs?
    40:40 How do VCs view companies in Fundraising Mode?
    46:10 The Fundraising Process in a Company
    48:15 Is the Fundraisngprocess Transactional, or do Relationships matter?
    51:00 Fundraising – Similarities and Differences between the US and the European Approach
    56:50 Entrepreneurship and Investors – Lifestyle or a Job?
    01:00:00 The Role of Money in Different Societies
    01:04:00 Why Do VCs Search for Exits?
    01:11:00 Valuation Expectations of VCs
    01:14:00 It is all about growth
    01:19:00 When Does it Make Sense to Reach out to VCs?
    01:23:00 Differences in the Value of Information in the B2B and B2C world
    01:27:00 The Pros and Cons of Being an Investor or Entrepreneur
    01:30:00 Spirituality, Investment, and Entrepreneurship
    01:34:30 What is the most important thing to consider when reaching out to VCs?
    Support the show (https://lsg2g.substack.com/subscribe?)

    • 1 hr 39 min
    #46: Wolfgang Kienreich - An Introduction to Know-Center: How Artificial Intelligence Will Change all Industries

    #46: Wolfgang Kienreich - An Introduction to Know-Center: How Artificial Intelligence Will Change all Industries

    Here is my conversation with Wolfgang Kienreich, CBO of Know-Center.

    Episode Links:
    Article to the Episode: https://lsg2g.substack.com/p/46-an-introduction-to-know-center
    Youtube: https://youtu.be/eTU5zROX5E4
    Wolfgang Kienreich: https://www.linkedin.com/in/wolfgang-kienreich-8350b899/
    Know Center: https://www.linkedin.com/company/know-center/

    Podcast Links:
    Podcast Website: https://www.lifescienceget2gether.com/
    Community Partner: https://linktr.ee/lsg2g
    Christian Soschner: https://linktr.ee/soschner
    LSG2G Twitter: https://twitter.com/LGet2gether
    LSG2G Linkedin: https://www.linkedin.com/company/life-science-get2gether
    Podcast Episodes: https://pod.link/1493847125
    Episodes on YouTube:  https://www.youtube.com/playlist?list=PLlZfrwd6iXrQ3LIANISUpP22seS2CsCEV

    Timestamps:
    For those who want to listen to specific parts of the episode, here are the timestamps:

    00:00 Introduction
    01:45 What is Fact and What is Fiction in Artificial Intelligence?
    05:45 Artificial Intelligence in Autonomous Driving
    07:30 AI in Language Translation and Understanding
    11:00 AI in Education
    12:20 How AI Improves Drug Discovery and Development
    15:00 Analyzing Health Data under GDPR
    16:55 How Wearable Technology Can Support Scientists to Get More Insights into the Development of Diseases
    18:15 European North Star Projects in AI
    20:45 Starting Point for SME Entrepreneurs in AI
    24:00 The History of the KNOW Center
    27:20 Industry Partners of the KNOW Center and Use Cases Developed with them
    31:30 How Does AI Affect Labour?
    34:05 Innovation Speed and AI
    36:00 The Role of AI in Search
    41:00 AI and Recommendation Management
    43:00 Potential in Assisted Living
    44:30 What is a Digital Twin?
    47:35 Recommendation to SMEs to Approach KNOW Center
    Support the show (https://lsg2g.substack.com/subscribe?)

    • 49 min
    #45: Jama Nateqi - 5 Habits of Successful Entrepreneurs

    #45: Jama Nateqi - 5 Habits of Successful Entrepreneurs

    Here is my conversation with Jama Nateqi, CEO of Symptoma.

    Episode Links:
    Article to the Episode: https://lsg2g.substack.com/p/45-hidden-secrets-to-successful-entrepreneurship
    Youtube: https://youtu.be/VOBc7pfqWOI
    Jama Nateqi: https://www.linkedin.com/in/jama-nateqi/
    Symptoma: https://www.linkedin.com/company/symptoma/

    Podcast Links:
    Podcast Website: https://www.lifescienceget2gether.com/
    Community Partner: https://linktr.ee/lsg2g
    Christian Soschner: https://linktr.ee/soschner
    LSG2G Twitter: https://twitter.com/LGet2gether
    LSG2G Linkedin: https://www.linkedin.com/company/life-science-get2gether
    Podcast Episodes: https://pod.link/1493847125
    Episodes on YouTube:  https://www.youtube.com/playlist?list=PLlZfrwd6iXrQ3LIANISUpP22seS2CsCEV

    Timestamps:
    For those who want to listen to specific parts of the episode, here are the timestamps:

    00:00:00 Kick-Off
    00:02:12 Intro Jama Nateqi – Give up your Freedom to gain Freedom
    00:03:47 Sleeping Habit
    00:04:53 Benefits of Waking Up Early
    00:05:43 What Is More Important – Quality or Quantity of Sleep?
    00:14:30 Why Making Your Bed Matters
    00:17:31 How to Achieve Peak Performance
    00:18:25 Lack of Sleep and its Impact on IQ
    00:19:20 Symptoma and Working Hours
    00:21:00 Meditation
    00:30:00 Deep Work & Digital Drugs
    00:36:00 Screentime – Modern Technology – Blessing or a Burden?
    00:45:00 Does Free Will Exist?
    00:53:00 Bad and Good – Yin And Yang
    00:56:00 The Power of Habit
    01:04:00 The Amazon Case 
    01:06:30 Never Stop Learning
    01:08:00 The Role of Exercising
    01:12:30 Health Benefits of Exercising
    01:16:00 The Benefits of “Don’t Demand too Much of Yourself.”
    01:20:00 New Year’s Resolutions
    01:23:00 Setting Goals in the Right Size
    01:26:00 The Habits of Setting Daily Goals & Time blocking
    01:33:00 Attitude to Failure
    01:35:00 About Nutrition
    01:39:25 Why conserving willpower is crucial for deep work
    01:43:00 Journaling
    01:45:00 Meaning of Life & Purpose of Businesses
    01:55:00 Finding the Right Team for a Vision
    02:06:00 What is Your Biggest Success in Life?
    02:10:00 What is the most important habit?
    Support the show (https://lsg2g.substack.com/subscribe?)

    • 2 hr 12 min
    #44: Tero Weckroth - Private and Public Investments - Similarities and Differences from the Crowdfunding and Angel Perspective

    #44: Tero Weckroth - Private and Public Investments - Similarities and Differences from the Crowdfunding and Angel Perspective

    Here is the conversation with Tero Weckroth, Business Angel and Investment Expert from Finland about Public and Private Investments.

    Episode Links:
    Article to the Episode: https://lsg2g.substack.com/p/44-private-and-public-investments
    Video to the Episode: https://youtu.be/7WDHWOyaPQQ
    Tero Weckroth: https://www.linkedin.com/in/tero-weckroth-5b927/
    Chessboxing: https://www.nordicchessboxing.com/

    Podcast Links:
    Podcast Website: https://www.lifescienceget2gether.com/
    Community Partner: https://linktr.ee/lsg2g
    Christian Soschner: https://linktr.ee/soschner
    LSG2G Twitter: https://twitter.com/LGet2gether
    LSG2G Linkedin: https://www.linkedin.com/company/life-science-get2gether
    Podcast Episodes: https://pod.link/1493847125
    Episodes on YouTube:  https://www.youtube.com/playlist?list=PLlZfrwd6iXrQ3LIANISUpP22seS2CsCEV

    Timestamps:
    For those who want to listen to specific parts of the episode, here are the timestamps:

    (0:00) Opening words
    (0:30) Introduction Tero Weckroth
    (3:00) Life Science in Finland
    (8:30) Life Science Investments for Business Angels
    (22:00) Alzheimer Drug Development and Diagnostics – Biogen and Combinostics
    (26:40) What is the Right Pricing for Drugs on the Market?
    (30:00) Availability of Capital for Early-Stage Drug Development
    (33:00) Importance of a Team
    (38:00) Public Investments and Crowdfunding
    (44:00) Risk Management for Investors
    (46:00) Differences between Privat and Public Investment and Crowdfunding
    (49:30) Reddit – New Development on the Stock Market
    (01:00:00) New Macroeconomic Era?
    (01:06:00) Cash, Gold, or Digital Gold?
    (01:15:00) Technological Evolvement in the Investment Banking World
    (01:20:00) Effects of the Pandemic on Regulations
    (01:25:00) Cryptocurrencies - Bitcoin, Cardano, Etherum & co.
    Support the show (https://lsg2g.substack.com/subscribe?)

    • 1 hr 34 min
    #43: Tilmann Buerckstuemmer and Thomas Moser - Gene-Editing - The Next Game-Changing Technology?

    #43: Tilmann Buerckstuemmer and Thomas Moser - Gene-Editing - The Next Game-Changing Technology?

    Thomas Moser and Tilmann Buerckstuemmer lead the Austrian Life Science Company Aelian Biotechnology.

    Episode Links:
    Article to the Episode: https://lsg2g.substack.com/p/gene-editing-the-next-game-changing-d3f
    Video to the Episode: https://youtu.be/3bf7ChYUHLE
    Aelian Biotechnology: https://aelian.bio/
    Thomas Moser: https://www.linkedin.com/in/thomas-moser-79819a5/
    Tilmann Buerckstuemmer: https://www.linkedin.com/in/tilmann-burckstummer-19b65949/

    Podcast Links:
    Podcast Website: https://www.lifescienceget2gether.com/
    Community Partner: https://linktr.ee/lsg2g
    Christian Soschner: https://linktr.ee/soschner
    LSG2G Twitter: https://twitter.com/LGet2gether
    LSG2G Linkedin: https://www.linkedin.com/company/life-science-get2gether
    Podcast Episodes: https://pod.link/1493847125
    Episodes on YouTube:  https://www.youtube.com/playlist?list=PLlZfrwd6iXrQ3LIANISUpP22seS2CsCEV

    Timestamps:
    For those who want to listen to specific parts of the episode, here are the timestamps:
    (00:00) Introduction
    (02:23) Introduction Thomas Moser
    (05:45) Introduction Tilmann Bürckstümmer
    (08:40) Aelian Biotechnology
    (10:20) The Science Behind Aelian
    (17:50) Life Science Business Model
    (27:00) How to Setup Business Relationships in Life Science
    (34:35) Gene Editing - Why Did it Create Such a Hype?
    (41:00) History of Gene Editing with Insights Into CRISPR/Cas9
    (45:30) Vienna - Part of The CRISPR Community
    (47:50) IP of CRISPR
    (50:00) CRISPR - Real Life Use Cases
    (55:05) CRISPR in Cancer Research
    (59:20) Are Genetically Altered Human Beings Possible?
    (01:04:20) Genetically Enhanced Human Beings - Reality or SciFi?
    (01:08:00) Gene Editing and its Role in Agriculture
    (01:12:00) SARS-CoV-2 - What Role Did CRISPR Play in Fighting the Pandemic?
    (01:12:20) CRISPR Screen for SARS-CoV-2 - Technology of Aelian Biotechnology
    (01:15:00) Drug Discovery for SARS-CoV-2 with CRISPR
    (01:18:00) Fundraising for Life Science Companies
    (01:27:00) Comparison of the Investment Culture in Europe and the United States
    (01:31:00) Major Players in the CRISPR Field
    (01:32:00) CRISPR - IP Landscape
    (01:44:00) Final Question: Advice for First Time Entrepreneurs
    Support the show (https://lsg2g.substack.com/subscribe?)

    • 1 hr 47 min
    #42: Johannes Sarx and Philipp Hainzl - LISA - Life Science in Austria

    #42: Johannes Sarx and Philipp Hainzl - LISA - Life Science in Austria

    Have you ever wondered what role the small country Austria - located in the center of Europe - plays in Life Science?
    Then listen to the managing directors of LISAvienna, Johannes Sarx, and Philipp Hainzl. 
    LISAvienna is a joint life science platform operated by Austria Wirtschaftsservice and the Vienna Business Agency. On behalf of the Austrian Federal Ministry for Digital and Economic Affairs and the City of Vienna, it contributes to the advancement of life sciences in Vienna. 
    LISAvienna supports innovative biotech, pharmaceutical, medical device, and digital health companies in Vienna that develop and market new products, services, and processes. The platform links these companies with development partners and key customers. 
    As a central knowledge carrier, LISAvienna provides input for decisions to advance the life sciences in Vienna and contributes to positioning the city of Vienna as one of the leading European innovation centers.
    If you want to learn more about the Life Science Hot Spots in the center of Europe, then this episode is for you.

    In this talk we discussed the situation of Life Science in Austria and covered topics like
    Public FundingLife Science ConferencesInfrastructureAccess to global talent andprivate funding as well as the pharma industry.Join us for a colloquial chat over Life Science and Entrepreneurship.

    Conference in person in fall in Austria as discussed in the Episode:

    The European Forum for Industrial Biotechnology and the Bioeconomy (EFIB)will take place in #Vienna this year, and is themed “Delivering the EU Green Deal: Industrial biotechnology into business”. Join the dialogue on how biotech can enable a more circular and sustainable future. As EFIB’s local partner, LISAvienna is looking forward to connecting you to experts in the region. Mark your calendar for October 6-7, 2021 and join us at Austria Center Vienna - Internationales Kongresszentrum.

    This is a great opportunity to grow your network.

    Learn more about the regional expertise, potential partners and new products and services online. Many of these breakthrough innovations will be showcased at EFIB in Vienna.
    Image: acv.at / begehungen.de
    https://lnkd.in/euT5eRe
    Speaker:
    Christian Soschner
    Johannes Sarx
    Philipp Hainzl
    Organizations:
    CS Life Science Invest
    LISAvienna
    Support the show (https://lsg2g.substack.com/subscribe?)

    • 44 min

Top Podcasts In Business